PhotonPharma is an immuno-oncology company with a break-through technology that stimulates a patient’s own immune system to seek out and destroy their cancer cells. We have a patent protected process that precisely inactivates DNA/RNA of a patient’s own tumor cells while leaving the cells alive with all of unique antigens targets intact. The process is simple, fast and inexpensive. A patient’s tumor cells can be extracted, inactivated and administered back on the same day. Efficacy and safety has been demonstrated in a canine trial and in murine studies. PhotonPharma is ready to file IND this year for human clinical trials.